The 17th ESDPPP congress was held in Basel Switzerland, from 28-30 May 2019.
The following topics were covered at the meeting:
- How to better use model-based adaptive trial design in paediatrics
- Development of an international guideline on paediatric extrapolation (ICH)
- Child friendly, age-appropriate formulations: how important are excipients?
- Drug formularies for children: time for a global approach!
- Adverse drug reactions across the paediatric age continuum
- Personalized medicine in children: more than just development?
- Pharmacogenomics: a cornerstone of precision medicine for childhood cancer
- New emerging therapies for genetic diseases (e.g., mucopolysaccharidoses, Duchenne muscular dystrophy, spinal muscular dystrophies, cystic fibrosis)
- Immunotherapy for paediatric cancer
- Pharmacology of cannabis in adolescents
- Personalized optimal dosing computation in neonates and children with thyroid diseases
- How to dose neonates and children during ECMO, haemodialysis and haemofiltration
- Alternative avenues to perform Therapeutic Drug Monitoring: use of saliva, dry blood spots and exhaled air!
- Implementation of e-health devices in clinical and pharmacological research in kids
- The role of the placenta in fetal and perinatal pharmacology
- Drug-drug interactions and education of health care providers
- How to conduct a successful neonatal clinical trial: the example of inhaled steroids
- How to optimize the use of microdosing in the neonatal and paediatric pharmacology
- Optimal use of antibacterial agents in the neonatal and paediatric population across the globe
- The opioid epidemic: what is new in the area of neonatal abstinence syndrome
- How to optimize pharmacotherapy in paediatric obesity
- New approaches in the treatment of pulmonary hypertension
- Update on research infrastructures across the globe (i-ACT, IMI2, FDA-funded clinical trial research networks)